Risk Factors for Congenital Heart Disease: the Baby Hearts Study, a population-based case-control study by Dolk, Helen et al.
RESEARCH ARTICLE
Risk factors for congenital heart disease: The
Baby Hearts Study, a population-based case-
control study
Helen DolkID1☯*, Nichola McCullough1☯, Sinead Callaghan2‡, Frank Casey2‡,
Brian Craig2‡, Joanne Given1, Maria Loane1, Briege M. Lagan1, Brendan Bunting3,
Breidge Boyle1¤, Tabib Dabir4
1 Institute of Nursing and Health Research, Ulster University, Newtownabbey, Northern Ireland, United
Kingdom, 2 Department of Cardiology, The Royal Belfast Hospital for Sick Children, Belfast, Northern Ireland,
United Kingdom, 3 School of Psychology, Ulster University, Coleraine, Northern Ireland, United Kingdom,
4 Department of Genetic Medicine, Belfast City Hospital, Belfast, Northern Ireland, United Kingdom
☯ These authors contributed equally to this work.
¤ Current address: School of Nursing and Midwifery, The Queen’s University of Belfast, Belfast, Northern
Ireland, United Kingdom
‡ These authors also contributed equally to this work.
* h.dolk@ulster.ac.uk
Abstract
We investigated the role of maternal environmental factors in the aetiology of congenital
heart disease (CHD). A population-based case-control study (242 CHD cases, 966 controls)
was conducted using an iPad questionnaire for mother with linkage to maternity and first tri-
mester prescription records. Risk of CHD was associated with low maternal education (OR
adjusted for confounders 1.59; 95% confidence interval [CI], 1.02–2.49), pregestational dia-
betes (OR 4.04; 95% CI 1.00–16.28), self-reported maternal clotting disorders (adjOR 8.55,
95%CI 1.51–48.44), prescriptions for the anticlotting medication enoxaparin (adjOR 3.22,
95%CI 1.01–10.22) and self-reported vaginal infections (adjOR 1.69, 95%CI 1.01–2.80).
There was no strong support for the hypothesis that periconceptional folic acid supplements
have a protective effect, but there was a protective effect of frequent consumption of folate
rich fruits (adjOR 0.64, 95%CI 0.47–0.89). Compared to the most common pre-pregnancy
dietary pattern, CHD risk was associated with a poor diet low in fruit and vegetables (adjOR
1.56, 95%CI 1.05–2.34). Mothers of cases reported more pregnancy related stress (adjOR
1.69; 95% CI 1.22–2.34) and multiple stressors (adjOR 1.94, 95%CI 0.83–4.53). We found
no supportive evidence for CHD risk being associated with obesity, smoking, depression or
antidepressant use in this population. Our findings add to the previous evidence base to
show potential for public health approaches to help prevent CHD in future by modifying envi-
ronmental factors. Independent confirmation should be sought regarding elevated CHD risk
associated with maternal blood clotting disorders and their treatment, since we are the first
to report this.
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Introduction
Significant progress has been made in recent decades in relation to the earlier detection of con-
genital heart disease (CHD), both prenatally and neonatally, while advances in surgical and
other treatments have improved survival and quality of life. However, very little progress has
been made in primary prevention–modifying risk factors to reduce the number of affected
babies. The main exceptions are vaccination against congenital rubella [1]and the identifica-
tion of maternal pregestational diabetes as a strong risk factor which can be managed by better
glycaemic control in the periconceptional period [2].
Mechanisms for abnormal cardiac morphogenesis relate to disruption of the normal embry-
ological process occurring within the first 8 weeks of gestation [3]. The cardiogenic cords arise
from the mesoderm and develop a lumen prior to fusing to become the primitive heart tube at
around 21 days of gestation. The heart tube undergoes alignment and septation between 24
and 35 days. Disturbances in alignment lead to major heart defects including various forms of
Single Ventricle and Tetralogy of Fallot. Defects in septation may also occur at this stage while
deficiencies in development of the cardiac inlet and outlet valves occur between 5 and 8 weeks
of gestation. It is in early pregnancy therefore that we look at potential maternal environmental
exposures which may disrupt cardiac morphogenesis.
The association of Down Syndrome and other aneuploidies with CHD is well known. The
use of new genetic technologies has led to the identification of increasing numbers of babies
with CHD who have copy number variations or point mutations [4]. Exclusion of genetic syn-
dromes can potentially increase the sensitivity of aetiological research focusing on environ-
mental (non-genetic) causal factors of interest, while it is recognised that most CHD is likely
to be caused by multiple environmental and genetic factors acting together [4–6].
Scientific uncertainty surrounds the status of a number of common potentially modifiable
environmental exposures as risk factors for CHD. These include the protective effect of peri-
conceptional folic acid supplementation or fortification [7,8], maternal smoking [9,10], mater-
nal obesity [11–14] and maternal depression or antidepressant use [15–19]. These are all major
health determinants which negatively affect a range of pregnancy outcomes and can be tackled
by public health programmes as well as individual healthcare.
In this paper we report the results of a population-based case-control study, the Northern
Ireland Baby Hearts Study, which set out to test whether common risk factors (low folate/folic
acid and its nutritional context, maternal smoking, maternal obesity, maternal antidepressant
use and its mental health context, were associated with risk of CHD, as well as examining a
range of other maternal diseases, medications and exposures as risk factors.
Materials and methods
Study design
We conducted a case-control study with hybrid data collection methods linking maternal
iPad-assisted questionnaires (retrospective exposure data) to maternity and prescription rec-
ords (prospective exposure data), as described in detail elsewhere [20].
Case and Control definition and recruitment
Cases and controls were eligible if mothers were resident in Northern Ireland during preg-
nancy, aged at least 17 years and able to read English or Polish (the most common language
among non-English speakers).
Cases were babies with a congenital heart defect diagnosed prenatally or before the baby
was six months old in the single paediatric cardiology centre serving the entire Northern
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Ireland population. Babies with Trisomy 21, commonly associated with CHD, were excluded.
Babies with other genetic syndromes diagnosed after referral to the clinical genetics service
were also excluded (assessed by clinical geneticist TD on the basis of genetic and clinical infor-
mation). Babies who were stillborn with CHD were eligible for inclusion if diagnosis had been
made prenatally. Terminations of pregnancy for fetal anomalies are not legal in Northern Ire-
land. Cases of patent ductus arteriosus associated with preterm birth, patent foramen ovale or
small Atrial septal Defect (ASD 4mms or less on 2-dimensional echocardiography) were
excluded (not recruited or excluded from analysis, see Fig 1). Twenty-eight percent of cases
were diagnosed prenatally, 30% before they were one month old, and 42% thereafter. Case
mothers were recruited after a diagnosis of CHD from September 2014 to February 2017 [20].
Fig 1. Flow diagram of recruitment for cases (a) and controls (b).
https://doi.org/10.1371/journal.pone.0227908.g001
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Controls were babies without CHD, recruited at maternity outpatient departments, when
attending for a routine fetal anomaly scan at 18–22 weeks gestation in all 17 units across
Northern Ireland during the period June 2014 to February 2016. A “one month per unit”
approach achieved a representative sample of pregnant women in Northern Ireland [20], with
the researcher inviting all eligible women attending for their first anomaly scan during that
month in that unit to participate. As shown in Fig 1, twelve control babies subsequently went
on to be diagnosed with CHD (approximately the number expected at a rate of CHD in the
population of 8 per 1000), and these transferred to case status.
The recruited sample was 286 cases and 966 controls a recruitment rate of 62% and 67%
respectively (Fig 1), with refusal rate of 8% for each. 40 cases with a genetic syndrome, and
four cases with a minor CHD (patent foramen ovale) were excluded (Fig 1), leaving 242 cases.
Only one of the 242 non-genetic cases was a stillbirth and two babies died in the first week of
life. 35 cases were born preterm.
Cases were classified according to the information in the paediatric cardiology clinical data-
base by paediatric cardiologists (FC, BC) into one or more of 10 main categories based on ana-
tomical and clinical criteria [21] (Table 1). This classification using the International Paediatric
Cardiology Code provides a systematic segmental approach to the description of CHD from
systemic venous morphology through to the great arteries which has a strong parallel in
embryogenesis. It is shown here to allow the diagnostic spectrum to be compared with other
study populations. We do not give results specific to CHD type in this paper due to lack of sta-
tistical power but they are available on request.
Exposure data definition and sources
The exposure period of interest was the periconceptional period, defined as the three months
before conception (for longer acting exposures and women’s “normal” behaviours until they
recognise their pregnancy) and the first trimester.
Women were asked to complete a self-report questionnaire, available on iPad (at clinic
appointments) or in a paper version for postal return (Fig 1) [20]. Mothers of controls
Table 1. Frequency of cases by category of congenital heart defect.
No� %
Houyel et al (23) categories
1 Heterotaxy, including isomerism and mirror-imagery 0 0.0
2 Anomalies of the venous return 6 2.5
3 Anomalies of the atria and interatrial communications (including atrial septal defects) 20 8.3
4 Anomalies of the atrioventricular junctions and valves (including atrioventricular septal
defects and ostium primum defects)
11 4.5
5 Complex anomalies of atrioventricular connections 0 0.0
6 Functionally univentricular hearts (including hypoplastic left heart) 24 9.9
7 Ventricular septal defects (VSD) 70 28.9
8 Anomalies of the ventricular outflow tracts (including Tetralogy of Fallot and Transposition
of the Great Arteries)
39 16.1
9 Anomalies of the extrapericardial arterial trunks (including Great artery anomalies, including
Coarctation of Aorta)
65 26.9
10 Congenital anomalies of the coronary arteries 1 0.4
Missing 6 2.5
Total 242�
�excluding genetic syndromes; including one case with maternal history of severe CHD.
https://doi.org/10.1371/journal.pone.0227908.t001
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completed this at the time of their anomaly scan appointment (median 20 weeks gestation,
range 18–34 weeks gestation). Mothers of cases completed this after diagnosis, prenatally (13%
of cases) or postnatally (87% of cases) (Fig 1), median 56 weeks after the start of pregnancy.
Information was collected on: maternal and paternal age; maternal education; main home
postcode; occupation during the first trimester; previous pregnancy history; pregnancy plan-
ning; use of folic acid supplementation in the periconceptional period and consumption of
folic acid fortified foods during the first three months of pregnancy (from a list of all available
foods in NI at the time which were fortified with folic acid on a voluntary basis); frequency of
eating a range of food groups, focusing on food types with high folic acid content, during the
three months before pregnancy; smoking during the three months before pregnancy; alcohol
consumption in the three months before pregnancy; experience of negative life events (self or
someone close) and pregnancy related stress during the periconceptional period; history of
chronic health conditions diagnosed by a doctor (self and father of baby); maternal infections
and exposure to medications or treatments during the first trimester. For maternal depression
and other chronic health conditions, we examined the further details given on the time of diag-
nosis, and only considered diagnoses in the first trimester or before the index pregnancy.
Data were extracted from the Northern Ireland Maternity System records (NIMATS) record-
ing data collected by the midwife at booking (booking usually occurs at 10–12 weeks gestation);
including date of last menstrual period (LMP), previous pregnancy history; weeks gestation at
booking; Body Mass Index (BMI); experience of nausea; maternal and paternal smoking at
booking; maternal risk factors, mental health and wellbeing in the month prior to booking (two
standard questions relating to whether during the past month the woman had experienced
symptoms of “feeling down, depressed or hopeless”; or “little interest in or pleasure in doing
things”). Women who refused permission to access records (n = 23) or could not be traced on
the NIMATS system (n = 6) were treated as missing.
Pregestational diabetes was assessed from the self report questionnaire and verified by pre-
scription records or self declared medication with antidiabetics. Gestational diabetes was as
reported in the NIMATS database at any time during pregnancy, excluding any women with
pregestational diabetes.
There is high immune status to rubella in the pregnant population and no recent reported
cases of congenital rubella. No rubella was reported among maternal risk factors in the mater-
nity data for cases or controls.
We extracted information on medications prescribed during the periconceptional period
from the Northern Ireland Enhanced Prescribing Database (EPD), focusing on British National
Formulary chapters 3 (Respiratory system); 4 (Central nervous system); 5 (Infections); 6 (Endo-
crine system) and 9 (Nutrition and blood). Data for women who refused permission to access
prescription records (25 controls, 4 cases) or had no available health and care number (4 cases,
5 controls) were treated as missing.
Postcode of residence in the first trimester was linked to the Northern Ireland Multiple
Deprivation Measure to obtain the area quintile of socioeconomic deprivation [22].
Statistical analysis
Crude and adjusted Odds Ratios (OR) with 95% Confidence Intervals (CI) were estimated using
unconditional logistic regression, in Stata v12, with listwise deletion. We explored each risk fac-
tor/covariate using univariable models with the presence or absence of CHD (case/control sta-
tus) as the dependent variable. We then constructed multivariate logistic regression models.
In multivariate models, cases and controls with pregestational diabetes were excluded as
this is a known strong risk factor for CHD, is associated with some other risk factors, and
Risk factors for congenital heart disease
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cannot be successfully adjusted for due to very small numbers affected. We included as covari-
ates sociodemographic factors (maternal age, previous pregnancy, maternal education, socio-
economic deprivation of area of residence) and common risk factors which were potentially
associated with CHD according to the literature: folic acid supplementation [7,8], smoking
[9,10], BMI category [11–14], antidepressant prescription in first trimester [15–19], dietary
class [23–25] (except for analysis of individual food types), pregnancy stress and multiple
stressors [26–28]. 9.7% of cases/controls were excluded due to at least one missing value.
We considered that Odds Ratios with a Confidence Interval not including 1 on univariable
or multivariate analysis and where adjustment for confounders did not greatly shift the point
estimate towards 1 constituted supportive evidence for association with CHD.
For medications, we analysed prescriptions issued in the three months following the LMP.
Where there was more than 15 days discrepancy between LMP as recorded by NIMATS and
other estimates of LMP from self-reported data, the data were inspected for errors and either
the most consistent value was chosen (53 controls, 8 cases), or LMP was set to missing (n = 7).
We conducted some chi square analyses (p<0.1) of the association between risk factors in
our control population to inform interpretation: the relationship between maternal age and
the main risk factors (covariates) as listed above, the relationship between maternal education
and the main risk factors, and the relationship between diet and obesity. We did not systemati-
cally address interaction between risk factors on risk of CHD, except the hypothesis suggested
in the literature [29] of an interaction between smoking and obesity (by computing odds ratio
for smoking within overweight/obese subgroup).
Latent Class modelling, using MPlus 6.1, was used to identify groups of women with similar
dietary behaviour (a “latent variable”) based on its impact on the frequency of consumption of
different foods [30] [31]. A likert scale of frequency of consumption was used, except for liver
which was categorised as ever eaten/never eaten. Models ranging from 1 to 6 classes were esti-
mated using Maximum Likelihood estimation with robust standard errors. All thresholds were
freely estimated across classes for each food/food group (i.e. no constraints were made on esti-
mated parameters). The optimum number of classes was determined based on a combination
of: (i) model fit (the Loglikelihood, Bayesian Information Criterion (BIC), sample size adjusted
BIC (SSABIC), Akaike Information Criterion (AIC); (ii), the accuracy with which models
classified individuals into their most likely class (Entropy); (iii) a statistical model comparison
(Lo-Mendell-Rubin Adjusted Likelihood ratio (LMR)); and (iv) substantive interpretation.
The most parsimonious solution was chosen. For each study participant their most likely class
membership (based on posterior probabilities), was used in further analyses.
The choice of variables to analyse was as follows:
1. The primary hypotheses concerned folic acid supplements, obesity (BMI), smoking, depres-
sion/antidepressants. All related variables were analysed (e.g. diet, stress). All major socio-
demographic and reproductive history variables were analysed as descriptive variables and
as potential confounders.
2. Exploratory analysis (hypothesis generating analysis) concerned all other recorded exposures
where there were at least 3 exposed cases. In multivariate analyses of these variables, we
adjusted for the same covariates as selected in the analyses of primary hypotheses. As recom-
mended [32], we did not make multiple comparison adjustments, but interpreted the find-
ings in the light of the multiple comparisons made. Unless the univariate analysis showed
statistically significant results, we put these results in S1 to S3 Tables for future meta-analyses.
Information about the dataset and Stata scripts can be found at https://doi.org/10.21251/
5b8fabfa-f4c5-465a-ba3d-cadf285313b3.
Risk factors for congenital heart disease
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Ethics and governance
Ethical approval for the study was obtained in 2014 from the Office for Research Ethics Com-
mittees Northern Ireland (ORECNI; 14NI0027) and each Health and Social Care Trust in NI
gave Research Governance approval. All participants gave written informed consent, which
included discrete consent options to allow access to medical records.
Results
Sociodemographic and reproductive characteristics
Cases and controls were similar in maternal age and parity (Table 2). One third had not
planned to become pregnant, not differing significantly between cases and controls (Table 2).
Cases were more likely than controls to have the lowest level of maternal education (adjOR
1.59, 95%CI 1.02–2.49; Table 2). There was no association with socioeconomic deprivation of
area of residence (Table 2).
We examined the relationship of maternal age and education with our main risk factors of
interest. In our population, both young maternal age and low maternal education were associ-
ated with not taking preconceptional folic acid, poor diet, smoking, and taking antidepres-
sants. Obesity was associated with low maternal education but not maternal age. Multiple
stressors were associated with younger maternal age but not education. Pregnancy stress was
associated with neither maternal age nor maternal education. Adjusting for these risk factors
had little impact on the Odds Ratio for low maternal education (Table 2).
Maternal diabetes and obesity
Pregestational Diabetes was strongly associated with CHD (OR 4.04, 95%CI 1.00–16.28
Table 2) though infrequent (1.7% of cases). The CHD diagnoses were two VSD, one Transpo-
sition of Great Arteries, and one Double Inlet Left Ventricle. Of the eight cases/controls with
diabetes, seven had not planned to become pregnant, six had a previous pregnancy, and only
two had taken preconceptional folic acid.
Excluding pregestational diabetes, 5.7% of cases and 4.4% of controls were diagnosed with
gestational diabetes: OR 1.30, 95%CI 0.67–2.55; (Table 2).
Obesity, based on BMI at booking, was not associated with CHD risk, before or after adjust-
ment for diabetes and other covariates (Table 3).
Folic acid and other dietary variables
Most women were taking folic acid by the end of their first trimester (Table 3). None of the
measures relating to folic acid supplements (self-reported non-use in first trimester or use
after 6 weeks gestation, and not starting supplements preconceptionally as reported to the
midwife) were significantly associated with CHD risk (Table 3).
Three quarters of the women stated they were consuming at least one type of food (cereal,
cereal bars, breads or spreads) fortified with folic acid (Table 3). There was a non-significant
trend for the number of types of fortified foods consumed to be associated with a lowering of
CHD risk.
Three dietary classes were delineated (Fig 2): “Moderate Fruit and Vegetable” (38% of the
study population), “Varied Diet” in particular with the highest fruit and vegetable consump-
tion (33.4%) and “Poor Diet” in particular with low fruit and vegetable consumption (28.6%).
Compared to the largest dietary group, a higher risk was found for “poor diet” (adjOR 1.56,
95%CI 1.05–2.34; Table 3). Diet was not significantly associated with obesity in our population
(p = 0.92).
Risk factors for congenital heart disease
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Table 2. Association between maternal risk factors (sociodemographic, reproductive history and diabetes) and congenital heart defects.
CHD cases (n = 242) Controls (n = 966)
No. % No. % OR (95%CI) adjOR� (95%CI)
Maternal age
<25 38 15.7 158 16.4 1.05 (0.68–1.62) 0.66 (0.38–1.14)
25–29 68 28.1 256 26.5 1.16 (0.81–1.67) 0.97 (0.64–1.47)
30–34 80 33.1 350 36.2 Ref Ref
35+ 56 23.1 202 20.9 1.21 (0.83–1.78) 1.17 (0.77–1.79)
Paternal Age
<25 18 7.44 92 9.52 0.76 (0.43–1.34) 0.57 (0.25–1.27)
25–29 51 21.1 231 23.9 0.86 (0.58–1.27) 0.68 (0.41–1.12)
30–34 78 32.2 304 31.5 Ref Ref
35+ 89 36.8 331 34.3 1.05 (0.74–1.47) 1.27 (0.83–1.95)
Missing 6 2.48 8 0.83
Maternal education
Low (compulsory only) 65 26.9 193 20.0 1.63 (1.13–2.34) 1.59 (1.02–2.49)
Medium (completed high school) 89 36.8 351 36.3 1.22 (0.88–1.70) 1.14 (0.77–1.68)
High (tertiary or other higher) 86 36.3 421 43.6 Ref Ref
Missing 1 0.42 1 0.10
Socioeconomic Deprivation quintile
1 (most deprived) 61 25.2 196 20.3 1.23 (0.78–1.96) 1.07 (0.63–1.81)
2 50 20.7 200 20.7 0.99 (0.62–1.60) 0.87 (0.52–1.46)
3 39 16.1 212 22.0 0.73 (0.44–1.20) 0.62 (0.36–1.06)
4 43 17.8 191 19.8 0.89 (0.55–1.46) 0.91 (0.54–1.53)
Previous pregnancy loss
None 160 66.1 627 64.9 Ref Ref
One 55 22.7 224 23.2 0.96 (0.68–1.35) 0.84 (0.56–1.26)
Two 12 4.96 62 6.42 0.76 (0.40–1.44) 0.69 (0.34–1.41)
Three or more 7 2.89 25 2.59 1.10 (0.47–2.58) 0.81 (0.29–2.30)
Missing 8 3.31 28 2.90
Pregnancy Planning
Did not plan to become pregnant 89 36.8 320 33.1 1.17 (0.88–1.58) 1.05 (0.70–1.58)
Trying to become pregnant (all other categories) 152 62.8 642 66.5 Ref Ref
Missing 1 0.41 4 0.41
Fertility Clinic (if trying longer than year)
Yes 22 59.46 57 50.0 1.45 (0.66–3.19) 2.00 (0.39–10.22)
No 13 35.14 49 43.0 Ref Ref
Missing 2 5.41 8 7.02
Pregestational Diabetes
Yes 4 1.65 4 0.41 4.04 (1.00–16.28) NA
No 238 98.4 962 99.6 Ref
Gestational Diabetes (excl pregestational diabetes)
Yes 12 8.33 36 3.74 1.30 (0.67–2.55) NA
No 202 84.9 790 82.1 Ref
Missing 24 10.1 136 14.1
�All multivariate models excluded cases/controls with pregestational diabetes and included the following variables: maternal age, previous pregnancy, maternal
education, socioeconomic deprivation of area of residence, dietary class, BMI category, folic acid supplementation, smoking, antidepressant prescription in first
trimester, pregnancy stress, multiple stressors. N = 1098 for cases/controls non-missing for all these variables and excluding cases/controls with pregestational diabetes.
https://doi.org/10.1371/journal.pone.0227908.t002
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Table 3. Association between maternal risk factors (folic acid, diet, smoking, alcohol, obesity) and congenital heart defects.
CHD cases
(n = 242)
Controls
(n = 966)
No. % No. % OR (95%CI) adjOR� (95%CI)
Self-report Folic acid Supplement
Did not take in first trimester 22 9.09 71 7.4 1.31 (0.77–2.23) 1.10 (0.60–2.01)
Started before pregnancy 93 38. 394 40.8 Ref Ref
Started after conception and before 6 weeks gestation 61 25.2 277 28.7 0.93 (0.65–1.33) 0.86 (0.57–1.29)
Started between 6–12 weeks gestation 57 23.6 215 22.3 1.12 (0.78–1.62) 1.01 (0.66–1.56)
Missing 9 3.72 9 0.9
Preconception Folic acid Supplement (as reported to the midwife)
Yes 78 32.2 340 35.2 Ref Ref
No 110 45.5 518 53.6 0.93 (0.67–1.28) 0.86 (0.60–1.24)
Missing 54 22.3 108 11.2
Fortified foods
No fortified foods 59 24.4 193 20.0 Ref
one type fortified food 98 40.5 375 38.8 0.85 (0.59–1.23) 0.82 (0.54–1.23)
two types fortified foods 58 24.0 257 26.6 0.74 (0.49–1.11) 0.78 (0.50–1.22)
three/four types fortified foods 27 11.2 141 14.6 0.63 (0.38–1.04) 0.61 (0.35–1.08)
Diet
Type 1—Moderate Fruit&Veg 80 33.1 378 39.1 Ref Ref
Type 2—Varied diet- High F&V 77 31.8 326 33.8 1.12 (0.79–1.58) 1.19 (0.81–1.75)
Type 3—Poor diet-Low F&V 85 35.1 260 26.9 1.54 (1.10–2.18) 1.56 (1.05–2.34)
Missing 0 0.00 2 0.21
Fizzy or high energy drinks
Fizzy or high energy every day 49 20.3 128 13.3 1.67 (1.15–2.42) 1.41 (0.90–2.21)
Fizzy or high energy 3+/wk 36 14.9 151 15.6 1.04 (0.69–1.55) 1.07 (0.68–1.70)
Fizzy or high energy <3/wk 155 64.1 675 69.9 Ref Ref
Missing 2 0.83 12 1.24
Food types eaten 3 or more times per week
Broccoli, brussel sprouts, spinach, peas, dark leafy veg (F) 72 29.8 236 24.4 1.30 (0.95–1.78) 1.37 (0.97–1.95)
Raw/lightly cooked veg (F) 48 19.8 245 25.4 0.72 (0.51–1.02) 0.91 (0.63–1.33)
Brown rice, chickpeas, kidney beans, lentils (F) 17 7.02 44 4.6 1.55 (0.87–2.77) 1.75 (0.93–3.31)
Oranges, strawberries, raspberries, pineapple, kiwi, cantaloupe, lemons, limes (F) 100 41.3 503 52.1 0.64 (0.48–0.85) 0.64 (0.47–0.89)
Other fruit (e.g apples, bananas, pears) 148 61.2 630 65.2 0.83 (0.62–1.10) 0.86 (0.62–1.20)
Tomatoes 81 33.5 313 32.4 1.05 (0.78–1.41) 1.06 (0.77–1.47)
Liver (F) 1 0.41 2 0.2
Other meats 185 76.5 713 73.8 1.11 (0.80–1.55) 1.30 (0.89–1.90)
Processed meats e.g. sausages, bacon 59 24.4 213 22.1 1.12 (0.81–1.57) 1.20 (0.83–1.74)
Fish 17 7.02 59 6.1 1.15 (0.66–2.00) 1.21 (0.66–2.24)
Dairy 217 89.7 856 88.6 1.10 (0.68–1.78) 1.17 (0.68–2.00)
Low calorie 21 8.68 117 12.1 0.68 (0.42–1.10) 0.68 (0.40–1.16)
Smoking (preconception) (self report)
Non smoker 179 74.3 749 77.5 Ref Ref
Light smoker 1–10 per day 44 18.3 149 15.4 1.24 (0.85–1.80) 1.12 (0.72–1.75)
Heavy smoker 11+ per day 18 7.47 66 6.85 1.14 (0.66–1.97) 0.66 (0.32–1.38)
Missing 1 0.4 2 0.2
Smoking (no. cigarettes/day at midwife booking)
non-smoker 182 75.2 779 80.6 Ref Ref
(Continued)
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Analysing individual diet components, eating oranges and other folate rich fruits 3 times a
week or more was associated with a significantly lower risk (OR 0.64, 95%CI 0.47–0.89).
Drinking fizzy or high energy drinks every day was significantly associated with CHD in
univariable analysis (OR 1.67, 95%CI 1.15–2.42) but this attenuated with adjustment for covar-
iates (adjOR 1.41, 95%CI 0.90–2.21, Table 3) since daily consumption of fizzy drinks was
associated with factors such as poor diet and low education. Inspection of data revealed no
discernible differences in risk between fizzy and high energy drinks but numbers were small.
Maternal smoking
Neither self-reported smoking before pregnancy, nor smoking as reported to the midwife
at booking, were significantly associated with the risk of CHD (Table 3). Subgroup analysis
focusing on the subgroup of obese or overweight women did not find self-reported smoking to
be a significant risk factor (light smokers adjOR 0.89, 95%CI 0.47–1.69, heavy smokers adjOR
0.58, 95%CI 0.22–1.56).
Table 3. (Continued)
CHD cases
(n = 242)
Controls
(n = 966)
No. % No. % OR (95%CI) adjOR� (95%CI)
1-10/day 29 12.0 93 9.63 1.33 (0.85–2.09) 1.07 (0.62–1.84)
11+/day 3 1.24 16 1.66 0.80 (0.23–2.78) 0.47 (0.10–2.24)
Missing 28 11.6 78 8.07
Smoking (paternal) (no. cigarettes/day at midwife booking)
Non smoker 159 65.7 682 70.6 Ref Ref
Light smoker 1–10 per day 34 14.1 127 13.2 1.14 (0.76–1.74) 1.08 (0.67–1.76)
Heavy smoker 11+ per day 17 7.02 68 7.04 1.07 (0.61–1.88) 0.84 (0.42–1.68)
Missing 32 13.2 89 9.21
Alcohol use (preconception) (self report)
Not at all or less than once a month 116 47.9 477 49.4 Ref Ref
once or twice a month 62 25.6 212 21.9 1.20 (0.85–1.70) 1.20 (0.81–1.79)
at least once or twice a week 63 26.0 275 28.5 0.94 (0.67–1.32) 1.05 (0.71–1.54)
missing 1 0.41 2 0.21
Obesity (BMI kg/m2)
Underweight (<18.50) 3 1.24 11 1.14 1.11 (0.30–4.03) 1.50 (0.39–5.77)
Normal (18.50–24.99) 113 46.7 458 47.4 Ref Ref
Overweight (25.00–29.99) 72 29.8 274 28.4 1.07 (0.76–1.48) 1.02 (0.71–1.46)
Obese (30.00–39.99) 41 16.9 167 17.3 1.00 (0.67–1.48) 0.98 (0.63–1.51)
Morbidly obese (40.00+) 7 2.89 33 3.42 0.86 (0.37–1.99) 0.70 (0.28–1.81)
Missing 6 2.48 23 2.38
Frequency of exercise in first three months of pregnancy
Infrequently/not at all 135 55.79 522 54.04 1.02 (0.71–1.48) 1.09 (0.71–1.66)
3/4 times a week 58 23.97 250 25.88 0.92 (0.60–1.40) 1.11 (0.69–1.79)
Every day /nearly every day 49 20.25 194 20.08 Ref Ref
Missing 0 0 0 0
� All multivariate models excluded cases/controls with pregestational diabetes and included the following variables: maternal age, previous pregnancy, maternal
education, socioeconomic deprivation of area of residence, dietary class (except for analysis of individual food types), BMI category, self reported folic acid
supplementation (except when analysing preconceptional folic acid reported to midwife), smoking (except when analysing smoking reported to midwife),
antidepressant prescription in first trimester, pregnancy stress, multiple stressors.
https://doi.org/10.1371/journal.pone.0227908.t003
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Maternal mental health, mental health related medication, and stress
None of the measures of maternal depression were significantly or strongly associated with
CHD. Odds ratios attenuated considerably after adjustment for confounders (Table 4). Anti-
depressant use, whether self-reported or based on prescription data, was not associated with
CHD risk.
Pregnancy-related stress was associated with CHD (adjOR1.69, 95%CI 1.22–2.34) and was
the most common form of stress (reported by 46% of cases and 32% of controls). Multiple
stress (the experience of three or more stressful events other than pregnancy related stress) in
the periconceptional period, was associated with CHD on univariable analysis (OR 2.12, 95%
CI 1.00–4.45), but was slightly attenuated controlling for pregnancy stress and other con-
founding variables (adjOR 1.94, 95%CI 0.83–4.53). A perceived lack of social support during
the first trimester of pregnancy from family and friends was non-significantly associated with
CHD (OR 1.98, 95%CI 0.98–3.99, adjOR 1.51, 95%CI 0.63–3.62), as was having counselling/
behaviour therapy in the first trimester (adjOR 1.89, 95%CI 0.64–5.57; Table 4).
Exploratory analysis of other risk factors
Odds ratios for CHD in relation to risk factors expected to be less common in our population,
or which did not constitute primary hypotheses based on previous literature, can be found in
the S1 to S3 Tables. Significant findings and related variables are shown in Table 5.
Self-reported maternal clotting disorder showed a significant relationship with CHD
(adjOR 9.69, 95%CI 1.64–57.4, based on 4 exposed cases and 2 exposed controls; Table 5).
Fig 2. Estimated probabilities of eating the different food types 3 or more times per week (liver: Eaten/not eaten), in each dietary class.
https://doi.org/10.1371/journal.pone.0227908.g002
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Table 4. Association between maternal mental health—Associated risk factors (maternal mental health conditions, stress, and associated medications) and congeni-
tal heart defects.
CHD cases
(n = 242)
Controls (n = 966)
No. % No. % OR (95%CI) adjOR� (95%CI)
Ever Diagnosed with depression (self-report)
No 201 83.1 838 86.8 Ref Ref
Yes 41 16.9 128 13.3 1.33 (0.91–1.96) 0.99 (0.60–1.65)
Ever Diagnosed with anxiety (self-report)
No 213 88.0 850 88.0 Ref Ref
Yes 29 12.0 116 12.0 1.00 (0.65–1.54) 0.90 (0.54–1.51)
Ever diagnosed Other mental health conditions (self-report)
No 236 97.5 949 98.2 Ref Ref
Yes 6 2.48 17 1.76 1.42 (0.55–3.64) 1.43 (0.48–4.26)
Last month depressed (at midwife booking)
No 203 83.9 855 88.5 Ref Ref
Yes 9 3.72 19 1.97 2.00 (0.89–4.47) 1.20 (0.45–3.20)
Missing 30 12.4 92 9.52
Last month little interest (at midwife booking)
No 205 84.7 858 88.8 Ref Ref
Yes 7 2.89 16 1.66 1.83 (0.74–4.51) 1.43 (0.52–3.97)
Missing 30 12.4 92 9.52
Antidepressants (any type) in first trimester (self-report)
No 235 97.1 932 96.5 Ref Ref
Yes 7 2.89 34 3.52 0.82 (0.36–1.87) 0.73 (0.29–1.82)
Antidepressants—SSRI/SNRI in first trimester (prescription data)��
No 215 88.8 882 91.3 Ref Ref
Yes 13 5.37 51 5.28 1.04 (0.56–1.96) 0.90 (0.44–1.83)
Missing 14 5.79 33 3.42
Counselling/ behaviour therapy (self-report)
No 235 97.1 952 98.6 Ref Ref
Yes 7 2.89 14 1.45 2.03 (0.81–5.07) 1.89 (0.64–5.57)
Missing 0 0 0 0.00
Stressful events in periconceptional period (Self-report)���
Death 29 12.0 101 10.4
Family ill 20 8.3 86 8.9
Move house 25 10.3 104 10.8
Lost job 13 5.4 39 4.0
Relation diffs 13 5.4 23 2.4
Alco abuse 8 3.3 16 1.7
Discrimination 3 1.2 7 0.7
Legal probs 7 3.0 14 1.5
Victim of crime 3 1.2 10 1.0
Arrest 5 2.1 6 0.6
Stressful events combined
None 159 65.7 673 69.7 Ref Ref
<3 72 29.8 271 28.1 1.12 (0.82–1.54) 1.10 (0.78–1.57)
3+ 11 4.55 22 2.28 2.12 (1.01–4.45) 1.94 (0.83–4.53)
Pregnancy related stress (Self-report)
No 129 53.3 658 68.1 Ref Ref
(Continued)
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Prescriptions in the first three months of pregnancy of the anti-clotting medication enoxaparin
was associated with CHD (enoxaparin: OR 3.05, 95%CI 1.05–8.89; adjOR 2.90, 95%CI 0.95–
8.81; Table 5), and to a lesser extent aspirin (OR 2.07, 95%CI 1.11–3.85, adjOR 1.73, 95%CI
0.86–3.47; Table 5).
The significant enoxaparin finding was further explored in relation to indication, dose, and
timing of exposure. Of the 14 women (cases/controls) receiving enoxaparin, two reported a
clotting disorder, and seven others reported two or more previous pregnancy losses, one of the
indications of enoxaparin treatment. After adjustment for previous pregnancy loss (not in
itself a significant risk factor; Table 2) in addition to other confounders, the enoxaparin odds
ratio changed little (adjOR 3.22, 95%CI 1.01–10.22) Of the 14 women receiving enoxaparin, 13
had a daily dose of 40 mg and one a daily dose of 60 mg; 5 were coprescribed aspirin at 75mg
per day. Seven of the fourteen started their prescriptions in the first six weeks of pregnancy
(one preconceptional, six at 4–5 weeks gestation), all but one of whom had multiple previous
pregnancy losses. Early exposure (in first 6 weeks) was more common for CHD cases: 5 of 6
cases vs 2 of 8 controls, an OR of 10.17 (95%CI 1.96–52.74).
Paternal raised blood pressure was significantly associated with CHD (adjOR 2.59, 95%CI
1.00–6.74; Table 5) but not maternal raised blood pressure (adjOR 1.04, 95%CI 0.37–2.92).
Maternal heart disease showed a non-significantly elevated risk (adjOR 2.13, 95%CI 0.34–
13.39; Table 5).
Vaginal infection or thrush was significantly associated with CHD (adjOR 1.69, 95%CI
1.01–2.80; Table 5).
Self-reported use of thyroid medication and prescribed levothyroxine during the first tri-
mester was non-significantly associated with an increased risk of CHD (self report: adjOR
1.70, 95%CI 0.75–3.89; prescription: adjOR 1.92, 95%CI 0.79–4.67; S2 Table). Other exposures
were not strongly or significantly associated with CHD, including nausea/vomiting, anti-nau-
sea medication, fever, influenza, kidney infection, self- reported asthma, and self- reported
anaemia (S1 and S2 Tables). Antibiotics were not significantly associated with CHD risk but
raised OR over 2 were observed for clarithromycin related and nitrofurantoin antibiotics. Self-
reported regular use of painkillers was associated with a protective effect (adjOR 0.29, 95%CI
0.08–0.97).
Table 4. (Continued)
CHD cases
(n = 242)
Controls (n = 966)
No. % No. % OR (95%CI) adjOR� (95%CI)
Yes 112 46.3 307 31.8 1.86 (1.40–2.48) 1.69 (1.22–2.34)
Missing 1 0.41 1 0.10
Perceived social support (Self-report)
No 12 4.96 25 2.59 1.98 (0.98–3.99) 1.51 (0.63–3.62)
Yes 228 94.2 939 97.2 Ref Ref
Missing 2 0.83 2 0.21
� All multivariate models excluded cases/controls with pregestational diabetes and included the following variables: maternal age, previous pregnancy, maternal
education, socioeconomic deprivation of area of residence, dietary class, BMI category, folic acid supplementation, smoking, antidepressant prescription in first
trimester (except for analysis of self reported antidepressants), pregnancy stress, multiple stressors.
��Prescribed SSRIs in the first three months of pregnancy were Citalopram, Escitalopram, Fluoxetine, and Sertraline; prescribed SNRI were Mirtazapine and
Venlafaxine.
��� We did not test stressors individually due to small numbers and lack of a theoretical basis for distinguishing individual stressors in this context.
https://doi.org/10.1371/journal.pone.0227908.t004
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Two common maternal occupations with significant chemical exposures, hairdresser and
cleaner, were not strongly associated with CHD (S3 Table).
Discussion
Sociodemographic factors
We found an excess risk of CHD associated with low maternal education, which persisted after
adjusting for other risk factors, suggesting that unmeasured environmental factors which asso-
ciate with maternal education (perhaps via individual socioeconomic status) are relevant and
need further research. Studies in the UK [33] and Canada [34] have found higher risk of CHD
associated with low socioeconomic level of area of residence, which we did not find. CHD may
constitute another dimension of socioeconomic inequalities in reproductive health.
Maternal disease
The fourfold risk of CHD associated with pregestational diabetes in our study is consistent
with the literature about this known causal factor, which is associated with poor periconcep-
tional glycaemic control [2,35]. Most of the women with diabetes in our study had not planned
to become pregnant, and thus were not accessing preconceptional care to improve glycaemic
control and reduce CHD risk, an area of healthcare that needs improvement. We found a low
Table 5. Exposures showing statistically significant associations with CHD on exploratory analysis, and related exposures (full results in Appendix).
CHD cases (n = 242) Controls (n = 966)
No. % No. % OR (95%CI) adjOR� (95%CI)
Maternal Clotting disorder (self report)
No 238 98.3 964 99.8 Ref Ref
Yes 4 1.65 2 0.21 8.10 (1.48–45.49) 9.69 (1.64–57.4)
Maternal Heart Disease (self report)
No 239 98.8 963 99.7 Ref Ref
Yes� 3 1.24 3 0.31 4.03 (0.81–20.09) 2.13 (0.34–13.39)
Maternal raised blood pressure (self report)
No 236 97.52 943 97.6 Ref Ref
Yes 6 2.48 23 2.38 1.04 (0.42–2.59) 1.04 (0.37–2.92)
Paternal raised blood pressure (maternal report)
No 216 89.3 920 95.2 Ref Ref
Yes 10 4.13 13 1.35 3.28 (1.42–7.57) 2.59 (1.00–6.74)
Missing 16 6.61 33 3.42
Vaginal thrush/infection
No 212 87.6 892 92.34 Ref Ref
Yes 30 12.4 74 7.66 1.71 (1.09–2.67) 1.69 (1.01–2.80)
Enoxaparin (BNF 2.8.1): Prescription in first three months
No 228 94.2 928 96.1 Ref
Yes 6 2.48 8 0.83 3.05 (1.05–8.89) 2.90 (0.95–8.81)
Missing 8 3.31 30 3.11
Aspirin (BNF 2.9.0): Prescription in first three months
No 218 90.1 904 93.6 Ref Ref
Yes 16 6.61 32 3.31 2.07 (1.11–3.85) 1.73 (0.86–3.47)
Missing 8 3.31 30 3.11
�including two controls with maternal congenital heart defects
https://doi.org/10.1371/journal.pone.0227908.t005
Risk factors for congenital heart disease
PLOS ONE | https://doi.org/10.1371/journal.pone.0227908 February 24, 2020 14 / 22
and non-significant risk of CHD associated with gestational diabetes, diagnosed in 4% of preg-
nancies during this period. A systematic review of the evidence [36] found that gestational dia-
betes (which occurs after cardiac morphogenesis is complete) was only associated with CHD
in the presence of obesity, and concluded this was likely to indicate undiagnosed pregestational
diabetes.
Obesity has been associated with a small excess risk of CHD between 10% and 30% [14]
[13]. This is not supported by our estimate of risk although within the confidence limits (OR
1.01, 95%CI 0.65–2.06). It is possible that the lack of association with obesity is a chance find-
ing, but other explanations can also be considered. The high prevalence of obesity (BMI 30+)
in our population—one quarter of women at booking with midwife–may be associated with
types of obesity less associated with metabolic syndrome and therefore less implicated in CHD
aetiology. A second possible explanation is that it is not obesity itself but the associated dietary
factors that are important. In our population, obesity was not associated with dietary class as
we measured it, but in other populations the relationship with diet may differ [12]. The associ-
ation with obesity in other studies may have been inflated because of bias in measurement
between cases and controls (in our study we used the same prospective measurement for cases
and controls thus reducing the opportunity for bias), or lack of control for confounding by
pregestational diabetes. Bias in other studies may also be caused by poor diagnostic data on
CHD resulting in transitory cardiac conditions associated with preterm birth (which is itself
related to obesity) being included as CHD. Our study excluded small transitory ASDs as well
as, for preterm births, patent ductus arteriosus. A large Swedish study [11] based on record
linkage and finding a 12% obesity-related excess of CHD recorded a prevalence of CHD of
1.6% of births, twice the prevalence expected, suggesting inclusion of transitory forms.
A potentially important new finding from the hypothesis-generating part of our study was
the threefold risk for CHD among women who were prescribed the anti-clotting medication
enoxaparin (adjOR 3.22, 95%CI 1.01–10.22), and women who self-reported blood clotting dis-
orders (adjOR 9.69, 95%CI 1.64–57.38). In our exploratory analysis of many risk factors, some
chance findings are likely, but we consider that these two apparently related findings are of
particular interest for independent confirmation in other study populations. The enoxaparin
risk was more highly associated with being prescribed the medication early in the first trimes-
ter (before 6 weeks gestation), consistent with a causal relationship. Enoxaparin is recom-
mended in case of recurrent consecutive pregnancy loss [37] on the basis that this is often
associated with abnormal blood clotting. There is no previous evidence of elevated malforma-
tion risk associated with enoxaparin but there is concern that the evidence base is so limited
[38]. Enoxaparin does not cross the placenta and therefore is a preferred alternative to warfa-
rin, a known teratogen, in case of pregnancy. If our findings are confirmed, further research is
needed to disentangle the effects of the medication and the possible underlying indication of
an undiagnosed blood clotting disorder or other factor associated with recurrent consecutive
pregnancy loss. We did not find a general association between CHD and multiple pregnancy
loss, but did not have a measure of recurrent consecutive loss. Recurrent pregnancy loss is
believed to be associated with heritable thrombophilias (an abnormality of blood coagulation)
which lead to impaired placental development and function [39]. If the underlying indication
(s) are causing the elevated CHD risk, then our data suggest that enoxaparin treatment in cur-
rent practice does not eliminate this risk or may be associated with CHD via prevention of
miscarriage.
We found a significant association with vaginal infection (adjOR 1.69, 95%CI 1.01–2.80)
which has not been previously reported. Previous studies have reported an association between
CHD and influenza [40] or fever [41], particularly in the absence of multivitamin use [41]. We
could find no evidence of an effect of fever or influenza.
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Folic acid and diet
In our population, the vast majority of women were taking folic acid supplements by the end
of the first trimester. We did not find any excess risk of CHD in the small group of women
who did not take supplements at all, or among those starting them after 6 weeks gestation. It
has been suggested that varying results of studies in different populations may relate to the
background folate/folic acid intake of the population [7,8]. In the UK, there is no mandatory
food fortification with folic acid, but voluntary food fortification reached three quarters of our
population. There was some indication in our data that eating more fortified foods conferred
a protective effect, but this was not statistically significant. Frequent consumption of folate rich
fruits conferred a protective effect, but needs to be considered within the entire dietary
context.
Our findings support a role for maternal diet in the aetiology of CHD. A poor diet, low in
fruit and vegetables and many of the other foods measured, was associated with a 56% excess
risk of CHD in our population compared to the most common dietary category. This type of
study cannot identify which dietary components are causally associated, and the possibility of
unmeasured confounding cannot be excluded, but our results do indicate the need for further
research on diet. Other studies have found a protective effect of better maternal diet quality in
the year preceding pregancy for conotruncal defects [8], a protective effect of a ‘prudent diet’
(high consumption of fruits, vegetables, whole wheat grains, reduced-fat dairy and fish) limited
to folic acid supplement users (23), a protective effect of high intakes of fish and seafood [24],
and a role for a range of nutrients beyond folate in relation to risk of Tetralogy of Fallot and d-
Transposition of the Great Arteries [25].
We found an association with daily consumption of fizzy (“Soda” or carbonated) and high
energy drinks, but this was attenuated when controlling for confounding factors such as diet
and maternal education (adjOR 1.41, 95%CI 0.90–2.21). We believe our study to be the first to
have investigated this. There is evidence that sugar or glucose levels in blood may be related to
CHD risk [42] [43] even among non-diabetics. On the other hand, sugar substitutes in diet
fizzy/soda drinks have been associated with a risk of diabetes [44,45]. Further research should
therefore differentiate sugar and sugar substitute drinks, and include dietary sources of sugar
which we did not assess.
Maternal smoking
Two meta-analyses of studies of smoking and CHD have estimated a 9–11% excess risk among
smokers, but without controlling for confounders [9,10]. Our study was not statistically pow-
erful enough to support or reject such a small excess risk, but our data do concur with the gen-
eral conclusion that a risk, if present, is small, and may depend on interaction with other
factors, for example those which affect hypoxia or maternal dyslipidaemia [29] or genetic vari-
ants [6]. We did not find an interaction with obesity as previously suggested [29]. Because of
the strong relationship between smoking and education (and other sociodemographic factors),
and between education and CHD, meta-analyses that do not control for confounding may
inflate estimates of risk.
Maternal mental health and related medication
We did not find an association between CHD risk and maternal use of antidepressants. While
meta-analyses [17,18,46,47] find an overall association between CHD risk and all or selected
SSRIs (particularly paroxetine which was not used in our population in pregnancy), with
pooled odds ratios generally lower than 1.5, continuing debate concerns whether this is due to
confounding by depression, co-medications or other co-exposures [19,48]. There may also be
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a role for genetic polymorphisms in population variation [49]. Our finding that maternal
depression itself was not a significant risk factor for CHD adds to a very small evidence base
on this question [50], and moreover our results suggest that there is considerable potential for
confounding in any association of depression with CHD, since point estimates of odds ratios
shifted considerably towards 1 after adjustment.
We did find CHD to be significantly associated with pregnancy stress in the first trimester,
which was very commonly reported (32% of controls) and therefore potentially important in
public health terms. There was also some evidence that multiple stressful events experienced
in the periconceptional period were also associated with CHD. Stress was retrospectively
reported and may have been perceived differently by mothers of cases (who had subsequently
also experienced the stress of their baby being diagnosed with CHD) and controls. However,
our findings are supported by other studies, both studies based like ours on retrospective
report of a variety of stressful life events [26], and studies free of recall issues based on linkage
with data on death or serious illness of family members [27,28]. The biological mechanism has
been hypothesised to be via hyperglycaemia or hypoxia through increased secretion of corti-
sone and catecholamines [27].
Strengths and limitations
The strengths of our study were that we were able to conduct a population-based assessment
in a geographical area served by a single diagnostic centre; we included well validated diagno-
ses of CHD, and excluded all genetic syndromes, patent ductus arteriosus associated with pre-
term birth, and small ASDs which need follow-up to distinguish from patent foramen ovale.
We had a rich dataset in terms of potential risk factors and confounders. We used a confiden-
tial user-friendly iPad questionnaire and linked the self-reported data to prospective informa-
tion from maternity records and prescription records to limit recall bias. We have analysed
elsewhere [20] our recruitment and found our study sample to be representative of the popula-
tion, with little evidence of selection bias. Our refusal rates were low and most non-recruit-
ment was because of logistic reasons unrelated to potential risk factors. We have also analysed
discordance between prescription data and self-reported data for medications, and found no
evidence of bias, but discordance around reporting of very early pregnancy exposures [20]
which varies by type of medication.
The main limitation of our study was that we did not achieve our target sample size for
cases [20] and therefore had limited statistical power—confidence intervals for less common
exposures were wide. it is possible that risk factors for specific CHD subtypes were masked by
studying CHD as a whole, and it was not possible to explore possible interactions between
exposures of interest. Our App tool is available for use by other studies and we see the current
study as a “seed” for further population-based studies in Europe which are sadly lacking.
The second major limitation of our study was that case mothers were interviewed later than
control mothers, so they had a longer period of recall, which may also have been affected by
intervening events. We have analysed this [20] and cannot find evidence of significant recall
bias, but it must nevertheless be recognised as a possibility for some exposures.
We excluded genetic cases diagnosed according to current UK health service practice for
CHD (referred for genetic testing due to the presence of dysmorphism, developmental delay
or multiple malformations). Some genetic cases may have remained in the data, and this
would tend to dilute odds ratios for environmental risk factors towards one. It is also possible
that a few cases of CHD may have been attributed to genetic causes despite an environmental
component to their aetiology. We may have underascertained stillborn babies with CHD and
those who died early, due to the added difficulty of recruitment [20].
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We studied maternal risk factors, and included paternal risk factors mainly for their value
in relieving potential maternal guilt among respondents, rather than their value as genetic, epi-
genetic [51] or environmental risk factors. Future research could pay more attention to pater-
nal factors.
Conclusions
Our results point to an unrealised potential for primary prevention of CHD by the modifica-
tion of risk factors such as maternal education, diet, maternal stress, and control of diabetes
and other maternal diseases. To realise this potential, further research is needed. Prevention of
CHD is likely to lead also to more general reproductive health improvement. On the other
hand, mothers of children with a congenital heart defect can generally be reassured that many
common exposures conferred no risk or a small risk, and that it is more likely that a combina-
tion of genetic and environmental factors, many as yet unknown, act together to disrupt fetal
heart development.
After a successful phase of improving survival and quality of life for children with CHD,
primary prevention is the next barrier to be surmounted.
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